• CLEVELAND, OHIO
  • 1-866-UH4-CARE
  • |
  • Search UH Online
Patients & Visitors Clinical Trials Listing
Print this pageEmail this pageBookmark Page

In This Section

Contact Information

General Phone Number
888-844-8447
216-844-8447
Mailing Address
11100 Euclid Avenue
Cleveland, OH 44106
Clinical Trials

Trial Name:

WSU 2104
Intro: A Phase II Study of GW572016 and Tamoxifen in Patients with Metastatic Breast Cancer Resistant to Single Agent Tamoxifen
Condition:
Description: The purpose of this study is to determine how safe and effective GW572016 in combination with tamoxifen will be for the treatment of advanced breast cancer. Patients will take six pills of GW572016 and one pill of tamoxifen, amounting to seven pills daily as well as keep a diary.
Criteria:
  1. Age ≥ 18 years
  2. Primary adenocarcinoma of the breast confirmed by histology or cytology. ER and/or PR+
  3. Locally advanced or metastatic disease not amenable to surgery or radiation with curative intent. Must not have rapidly progressive disease
  4. Must have failed hormonal manipulation with tamoxifen. May have received treatment with an aromatase inhibitor as first line therapy for metastatic disease prior to treatment with tamoxifen, but no other hormonal manipulation upon failing tamoxifen
  5. ECOG performance status 0 – 2 6. Patients must have normal bone marrow, liver and kidney function.
Contact: For Cancer Information, Current Clinical Trials, and Referral to a Physician please call (216) 844-5432 or (800) 641-2422

Participant Confidentiality:

All information regarding participation in Clinical Trials is treated with the utmost confidentiality. University Hospitals Case Medical Center and the Division of Clinical Research recognize and respect the confidentiality of this information. Access to information related to clinical trials and their participants is restricted to authorized clinical trials personnel only.

Back